Published in Mol Neurobiol on April 30, 2010
Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolism. Br J Pharmacol (2012) 0.78
Three-dimensional cell culture environment promotes partial recovery of the native corneal keratocyte phenotype from a subcultured population. Tissue Eng Part A (2013) 0.76
Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer (2002) 4.76
Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol (2009) 2.65
Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res (2000) 2.48
Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest (1988) 2.23
Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp Eye Res (2005) 2.04
Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest (1994) 1.84
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med (2002) 1.66
Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci U S A (1997) 1.32
Organization of collagen types I and V in the embryonic chicken cornea. Invest Ophthalmol Vis Sci (1986) 1.25
Platelet-activating factor receptor: gene expression and signal transduction. Biochim Biophys Acta (1995) 1.22
High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis (2009) 1.19
Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis. Exp Eye Res (2009) 1.17
Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing. Am J Pathol (2006) 1.14
Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB. Invest Ophthalmol Vis Sci (2000) 1.12
Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells. Invest Ophthalmol Vis Sci (2004) 1.12
A longitudinal study of trends in keratitis in Australia. Cornea (2008) 1.11
Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL/6 mice after corneal HSV-1 infection. J Interferon Cytokine Res (1999) 1.10
Significance of lipid mediators in corneal injury and repair. J Lipid Res (2009) 1.08
Growth factors and ocular wound healing. Eye (Lond) (1994) 1.00
Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor receptor antagonist. Arch Ophthalmol (2006) 0.97
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor. Am J Pathol (1990) 0.96
Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. Invest Ophthalmol Vis Sci (2006) 0.94
Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor. Invest Ophthalmol Vis Sci (2002) 0.93
The role of platelet-activating factor in the corneal response to injury. Prog Retin Eye Res (2002) 0.93
Susceptibility to TNF in the presence of inhibitors of transcription or translation is dependent on the activity of cytosolic phospholipase A2 in human melanoma tumor cells. J Immunol (1996) 0.91
Cytosolic phospholipase A2-{alpha} is an early apoptotic activator in PEDF-induced endothelial cell apoptosis. Am J Physiol Cell Physiol (2008) 0.91
Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice. Br J Pharmacol (1990) 0.89
Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Exp Eye Res (1991) 0.89
The alkali burned cornea I. Epithelial and stromal repair. Exp Eye Res (1976) 0.88
Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist. J Cataract Refract Surg (2004) 0.87
Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. Invest Ophthalmol Vis Sci (2000) 0.86
The cell shedding rate of the corneal epithelium--a comparison of collection methods. Curr Eye Res (1996) 0.84
TNFalpha is a potent inducer of platelet-activating factor synthesis in adipocytes but not in preadipocytes. Differential regulation by PI3K. Cytokine (2008) 0.84
Platelet-activating factor (PAF) enhances apoptosis induced by ultraviolet radiation in corneal epithelial cells through cytochrome c-caspase activation. Curr Eye Res (2001) 0.82
Platelet-activating factor preferentially stimulates the phospholipase A2/cyclooxygenase cascade in the rabbit cornea. Curr Eye Res (1995) 0.79
Surveillance of severe chemical corneal injuries in the UK. Br J Ophthalmol (2009) 0.79
Activation of the phospholipase/cyclooxygenase cascade in the rabbit cornea by platelet-activating factor is challenged by PAF receptor antagonists. J Ocul Pharmacol Ther (1995) 0.78
Prolonged effect of a new platelet-activating factor antagonist on ocular vascular permeability in an endotoxin model of uveitis. Curr Eye Res (1991) 0.76
p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem (2003) 1.99
Mapping the entire human corneal nerve architecture. Exp Eye Res (2010) 1.31
Topical combination of NGF and DHA increases rabbit corneal nerve regeneration after photorefractive keratectomy. Invest Ophthalmol Vis Sci (2005) 1.30
Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther (2010) 1.25
Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Invest Ophthalmol Vis Sci (2009) 1.20
Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity. Mol Vis (2004) 1.09
Significance of lipid mediators in corneal injury and repair. J Lipid Res (2009) 1.08
Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery. Prostaglandins Leukot Essent Fatty Acids (2010) 1.07
Epidermal growth factor synergism with TGF-beta1 via PI-3 kinase activity in corneal keratocyte differentiation. Invest Ophthalmol Vis Sci (2008) 1.05
HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway. Invest Ophthalmol Vis Sci (2004) 1.04
Mapping the nerve architecture of diabetic human corneas. Ophthalmology (2012) 1.02
Neuroprotectin D1 restores corneal nerve integrity and function after damage from experimental surgery. Invest Ophthalmol Vis Sci (2013) 0.99
Recovery of corneal sensitivity, calcitonin gene-related peptide-positive nerves, and increased wound healing induced by pigment epithelial-derived factor plus docosahexaenoic acid after experimental surgery. Arch Ophthalmol (2011) 0.98
Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor receptor antagonist. Arch Ophthalmol (2006) 0.97
Epidermal and hepatocyte growth factors, but not keratinocyte growth factor, modulate protein kinase Calpha translocation to the plasma membrane through 15(S)-hydroxyeicosatetraenoic acid synthesis. J Biol Chem (2004) 0.96
Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. Invest Ophthalmol Vis Sci (2006) 0.94
EGF stimulates lipoxin A4 synthesis and modulates repair in corneal epithelial cells through ERK and p38 activation. Invest Ophthalmol Vis Sci (2011) 0.94
Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor. Invest Ophthalmol Vis Sci (2002) 0.93
Comparative in vivo high-resolution confocal microscopy of corneal epithelium, sub-basal nerves and stromal cells in mice with and without dry eye after photorefractive keratectomy. Clin Experiment Ophthalmol (2007) 0.92
Association of protein tyrosine phosphatases (PTPs)-1B with c-Met receptor and modulation of corneal epithelial wound healing. Invest Ophthalmol Vis Sci (2008) 0.91
Wound-healing response and refractive regression after conductive keratoplasty. J Cataract Refract Surg (2006) 0.90
Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care (2011) 0.90
Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. FASEB J (2004) 0.90
Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Invest Ophthalmol Vis Sci (2004) 0.89
Platelet-activating factor overturns the transcriptional repressor disposition of Sp1 in the expression of MMP-9 in human corneal epithelial cells. Invest Ophthalmol Vis Sci (2007) 0.88
Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. Exp Eye Res (2002) 0.88
Healing process at the flap edge in its influence in the development of corneal ectasia after LASIK. Curr Eye Res (2006) 0.87
Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist. J Cataract Refract Surg (2004) 0.87
Platelet-activating factor induces permeability transition and cytochrome c release in isolated brain mitochondria. J Neurosci Res (2002) 0.86
Comparison of corneal wound-healing response in photorefractive keratectomy and laser-assisted subepithelial keratectomy. J Cataract Refract Surg (2005) 0.85
Protein kinase C alpha and epsilon differentially modulate hepatocyte growth factor-induced epithelial proliferation and migration. Exp Eye Res (2007) 0.83
Growth factor-induced proliferation in corneal epithelial cells is mediated by 12(S)-HETE. Exp Eye Res (2003) 0.83
PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Invest Ophthalmol Vis Sci (2005) 0.82
Corneal nerve architecture in a donor with unilateral epithelial basement membrane dystrophy. Ophthalmic Res (2013) 0.81
Regulation of Cdc42 expression and signaling is critical for promoting corneal epithelial wound healing. Invest Ophthalmol Vis Sci (2013) 0.81
A novel platelet activating factor receptor antagonist reduces cell infiltration and expression of inflammatory mediators in mice exposed to desiccating conditions after PRK. Clin Dev Immunol (2009) 0.80
Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS. J Ocul Pharmacol Ther (2011) 0.80
Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea (2005) 0.79
Lipoxin A₄ inhibits platelet-activating factor inflammatory response and stimulates corneal wound healing of injuries that compromise the stroma. Exp Eye Res (2012) 0.77
The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF). Curr Eye Res (2010) 0.76
Immunofluorescence of rabbit corneas after collagen cross-linking treatment with riboflavin and ultraviolet A. Cornea (2010) 0.75
Elovanoid-N32 or RvD6-isomer decrease ACE2 and binding of S protein RBD after injury or INFγ in the eye. Res Sq (2020) 0.75